AdvaMed: MedTech Grows During Device Tax Suspension

Among their survey results, AdvaMed reported that the suspended device tax was leading to member companies retaining jobs and investing in infrastructure, R&D and novel technology. Specifically:

• 73% of respondents increased or avoided reducing employment since the tax was suspended;
• 33% invested in a new research facility, lab, or research infrastructure;
• 83% reported increased R&D or avoided reducing R&D funding; and
• 23% reported increasing investment in start-up companies.